Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.80
+1.00 (3.47%)
Mar 24, 2026, 1:30 PM CST

Apex Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,9793,0433,0094,0282,5542,599
Market Cap Growth
-2.93%1.16%-25.31%57.73%-1.73%10.38%
Enterprise Value
2,4452,5942,6673,8422,3372,292
Last Close Price
29.8030.4528.9337.5422.6521.94
PE Ratio
18.4018.6823.5034.7914.0512.85
Forward PE
-13.8413.8413.8413.8413.84
PS Ratio
1.531.571.622.401.141.22
PB Ratio
1.591.631.652.241.411.48
P/TBV Ratio
1.621.661.692.301.461.58
P/FCF Ratio
20.5621.0110.0119.32-16.95
P/OCF Ratio
18.6019.019.1517.4895.9514.45
EV/Sales Ratio
1.261.331.442.291.041.08
EV/EBITDA Ratio
12.1212.8714.6518.608.997.86
EV/EBIT Ratio
17.3718.4420.7627.1113.2411.18
EV/FCF Ratio
16.8817.918.8818.43-14.95
Debt / Equity Ratio
0.060.060.070.090.100.16
Debt / EBITDA Ratio
0.540.540.640.710.670.95
Debt / FCF Ratio
0.760.760.410.74-1.86
Net Debt / Equity Ratio
-0.29-0.29-0.26-0.16-0.12-0.19
Net Debt / EBITDA Ratio
-2.65-2.65-2.61-1.41-0.83-1.17
Net Debt / FCF Ratio
-3.69-3.69-1.58-1.3921.76-2.22
Asset Turnover
0.800.800.790.700.870.80
Inventory Turnover
2.302.301.891.542.442.75
Quick Ratio
2.532.532.001.931.571.42
Current Ratio
3.873.873.443.932.902.24
Return on Equity (ROE)
8.82%8.82%7.07%6.40%10.16%11.90%
Return on Assets (ROA)
3.64%3.64%3.40%3.68%4.26%4.81%
Return on Invested Capital (ROIC)
8.95%9.00%7.53%7.49%10.65%14.91%
Return on Capital Employed (ROCE)
7.10%7.10%6.60%7.40%9.10%10.90%
Earnings Yield
5.47%5.35%4.25%2.87%7.12%7.78%
FCF Yield
4.86%4.76%9.99%5.18%-0.39%5.90%
Dividend Yield
4.17%-4.15%2.93%6.18%5.93%
Payout Ratio
73.63%73.63%85.90%120.86%71.48%54.06%
Buyback Yield / Dilution
-0.15%-0.15%-0.08%0.34%4.70%6.53%
Total Shareholder Return
3.98%-0.15%4.07%3.27%10.88%12.46%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.